{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:51:07Z","timestamp":1782953467304,"version":"3.54.5"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["1151906"],"award-info":[{"award-number":["1151906"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2025,9,16]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial diseases are a group of rare, chronic disorders with a significant disease burden; however, there is limited knowledge about their effects on the health-related quality of life (HRQoL) of patients and their carers. This study estimates HRQoL among adult patients with mitochondrial diseases and their carers, using the Assessment of Quality-of-Life 8D (AQoL-8D), a validated instrument for measuring health utilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety-nine adult patients and 24 carers were recruited to the Economic and Psychosocial Impacts of Caring for Families Affected by Mitochondrial Disease (EPIC-MITO) Study, based in New South Wales, Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Adult patients exhibited significantly lower utility values (0.52) compared with age-adjusted and gender-adjusted population norms (0.80; p&lt;0.001). Regression analysis shows that mental health disorders, sleep disorders, financial stress and female gender were associated with reduced HRQoL. Carers also demonstrated AQoL-8D utility values (0.70) significantly below age-adjusted and gender-adjusted population norms (0.81; p=0.01) reflecting the broader burden of mitochondrial diseases on families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>With increasing use of genetic testing and genomic sequencing, as well as hope for gene therapies, health utility values will be necessary for economic evaluations of new interventions for mitochondrial disease. This paper shows the substantial impact on HRQoL of mitochondrial disease measured through utilities. The utility values from this paper can inform future economic evaluations for interventions for patients with mitochondrial disease. Further, the paper demonstrated that mitochondrial disease not only reduces the HRQoL of patients but also impacts the HRQoL of carers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmg-2025-110896","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:20:34Z","timestamp":1758993634000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Health-related quality of life in patients with mitochondrial disease and their carers"],"prefix":"10.1136","volume":"63","author":[{"given":"Deborah","family":"Schofield","sequence":"first","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-6726","authenticated-orcid":false,"given":"Joshua","family":"Kraindler","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-6878","authenticated-orcid":false,"given":"Katherine","family":"Lim","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Tan","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameen","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, University of Sydney, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Crawley","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, University of Sydney, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"West","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Percival","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, University of Sydney, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayamala","family":"Parmar","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupendra","family":"Shrestha","sequence":"additional","affiliation":[{"name":"GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Sue","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, University of Sydney, St Leonards, New South Wales, Australia"},{"name":"Department of Neurology, Southeast Sydney Local Health District, Randwick, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"2026060805250931000_63.1.50.1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10545-018-0229-5","article-title":"Outcome measures for children with mitochondrial disease: consensus recommendations for future studies from a Delphi-based international workshop","volume":"41","author":"Koene","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"2026060805250931000_63.1.50.2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nmd.2012.12.012","article-title":"Initial development and validation of a mitochondrial disease quality of life scale","volume":"23","author":"Elson","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"2026060805250931000_63.1.50.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0806397"},{"key":"2026060805250931000_63.1.50.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2006.12.004"},{"key":"2026060805250931000_63.1.50.5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5694\/j.1326-5377.2010.tb03864.x","article-title":"Mitochondrial disease: recognising more than just the tip of the iceberg","volume":"193","author":"Sue","year":"2010","journal-title":"Med J Aust"},{"key":"2026060805250931000_63.1.50.6","unstructured":"Mito Foundation . Fact sheet: mitochondrial disease. 2019. Available: https:\/\/www.mito.org.au\/wp-content\/uploads\/2019\/01\/Fact-Sheet-Mitochondrial-Disease-October-2018.pdf"},{"key":"2026060805250931000_63.1.50.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.051"},{"key":"2026060805250931000_63.1.50.8","first-page":"e730","article-title":"Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis","volume":"99","author":"Davis","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2026060805250931000_63.1.50.9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-023-02746-x","article-title":"Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting","volume":"18","author":"Haque","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026060805250931000_63.1.50.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00098-3"},{"key":"2026060805250931000_63.1.50.11","unstructured":"Medical Services Advisory Committee (MSAC) . 1675 \u2013 whole genome sequencing for the diagnosis of mitochondrial disease. 2022. Available: http:\/\/www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/1675-public"},{"key":"2026060805250931000_63.1.50.12","unstructured":"Department of Health and Aged Care . Whole genome sequencing for the diagnosis of mitochondrial disease. 2023. Available: https:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/0FAE1338D92EA3A3CA258A6F0001701A\/$File\/FS%20-%20Whole%20genome%20sequencing%20for%20the%20diagnosis%20of%20mitochondrial%20disease.pdf"},{"key":"2026060805250931000_63.1.50.13","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026060805250931000_63.1.50.14","doi-asserted-by":"crossref","DOI":"10.1177\/2050312116671725","article-title":"SF-36 total score as a single measure of health-related quality of life: Scoping review","volume":"4","author":"Lins","year":"2016","journal-title":"SAGE Open Med"},{"key":"2026060805250931000_63.1.50.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0403-5","article-title":"Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation","volume":"11","author":"Verhaak","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"2026060805250931000_63.1.50.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106800"},{"key":"2026060805250931000_63.1.50.17","doi-asserted-by":"publisher","DOI":"10.1159\/000337703"},{"key":"2026060805250931000_63.1.50.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02411-9","article-title":"A conceptual disease model for quality of life in mitochondrial disease","volume":"17","author":"van de Loo","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2026060805250931000_63.1.50.19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mito.2020.09.005","article-title":"Mental health and health related quality of life in mitochondrial POLG disease","volume":"55","author":"Hikmat","year":"2020","journal-title":"Mitochondrion"},{"key":"2026060805250931000_63.1.50.20","unstructured":"The centre for international economics preventable burden of mito: reducing the cost and providing benefits to people with mitochondrial disease and their communities. 2014. Available: https:\/\/www.legislation.gov.uk\/ukia\/2015\/9\/pdfs\/ukia_20150009_en.pdf"},{"key":"2026060805250931000_63.1.50.21","unstructured":"UK department of health impact assessment of mitochondrial donation regulations. 2014. Available: https:\/\/www.legislation.gov.uk\/ukia\/2015\/9\/pdfs\/ukia_20150009_en.pdf"},{"key":"2026060805250931000_63.1.50.22","first-page":"102","article-title":"The development of a microsimulation model (mitomod) to estimate the economic impact of mitochondrial disease in adults","volume":"152","author":"Schofield","year":"2022","journal-title":"IJM"},{"key":"2026060805250931000_63.1.50.23","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-013-0036-x"},{"key":"2026060805250931000_63.1.50.24","doi-asserted-by":"crossref","unstructured":"Maxwell A , \u00d6zmen M , Iezzi A , et al . Norms for the aqol-6d and aqol-8d multi attribute utility instruments. Victoria: Centre for Health Economics Melbourne, Monash University, 2016.","DOI":"10.1007\/s11136-016-1337-z"},{"key":"2026060805250931000_63.1.50.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.02.017"},{"key":"2026060805250931000_63.1.50.26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10834-022-09820-9","article-title":"The Relationship Between Financial Worries and Psychological Distress Among U.S. Adults","volume":"44","author":"Ryu","year":"2023","journal-title":"J Fam Econ Issues"},{"key":"2026060805250931000_63.1.50.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-020-01456-3","article-title":"Health, subjective financial situation and well-being: a longitudinal observational study","volume":"18","author":"Downward","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2026060805250931000_63.1.50.28","doi-asserted-by":"publisher","DOI":"10.1177\/1474651410385864"},{"key":"2026060805250931000_63.1.50.29","unstructured":"Australian Institute of Health and Welfare . Life and work experiences of australians with chronic conditions. Canberra AIHW; 2021. Available: https:\/\/www.aihw.gov.au\/reports\/chronic-disease\/life-and-work-with-chronic-conditions"},{"key":"2026060805250931000_63.1.50.30","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18052422","article-title":"Australian Experiences of Out-of-Pocket Costs and Financial Burden Following a Cancer Diagnosis: A Systematic Review","volume":"18","author":"Bygrave","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026060805250931000_63.1.50.31","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-021-01121-2","article-title":"Sleep Disorders in Mitochondrial Diseases","volume":"21","author":"Brunetti","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2026060805250931000_63.1.50.32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.5664\/jcsm.4212","article-title":"Sleep disorders associated with primary mitochondrial diseases","volume":"10","author":"Ramezani","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"2026060805250931000_63.1.50.33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40142-018-0138-9","article-title":"Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies","volume":"6","author":"Muraresku","year":"2018","journal-title":"Curr Genet Med Rep"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-110896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:25:43Z","timestamp":1780921543000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-110896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,25]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/jmg-2025-110896"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-110896","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]}}}